• CLK2 Inhibition Overcomes Platinum Resistance in Ovarian Can

  2026-05-13

  This study identifies Cdc2-like kinase 2 (CLK2) as a critical mediator of platinum resistance in ovarian cancer by promoting DNA repair through BRCA1 phosphorylation. Targeting CLK2 provides a mechanistic rationale for overcoming chemoresistance, with implications for alternative splicing modulation and therapy development.

• IWR-1-endo: Wnt Signaling Inhibitor Workflows & Pitfalls

  2026-05-13

  IWR-1-endo delivers nanomolar potency and mechanistic specificity for Wnt/β-catenin pathway inhibition, enabling robust colorectal cancer research and regenerative biology studies. This guide distills experimental strategies, troubleshooting, and protocol optimizations for maximizing the utility of IWR-1-endo in advanced cell and animal models.

• Honokiol: Applied Workflows for NF-κB Inhibition in Cancer R

  2026-05-12

  Honokiol, a bioactive small molecule, is redefining cancer and inflammation assay design through potent NF-κB pathway inhibition and robust antioxidant activity. This article translates recent in vitro methodology advances into actionable, troubleshooting-rich workflows, empowering researchers to optimize Honokiol’s use across viability, angiogenesis, and immunometabolic studies. Discover protocol enhancements, evidence-backed troubleshooting, and perspective on Honokiol’s evolving research impact.

• Low-Cost OP-DLP Platform Enables High-Throughput Hydrogel Pr

  2026-05-12

  This study introduces an open-platform digital light printer (OP-DLP) for precise, high-throughput hydrogel synthesis and spatially controlled light activation in standard 96-well plates. The innovation streamlines the fabrication of thin, uniformly patterned hydrogels, addressing bottlenecks in cell-based assay reproducibility and scalability.

• HyperPFU™ high-fidelity DNA polymerase: Technical PCR Guidan

  2026-05-11

  HyperPFU™ high-fidelity DNA polymerase addresses the persistent challenge of amplifying long or GC-rich DNA fragments with high sequence fidelity and robust performance. It is recommended for workflows requiring blunt-ended, high-fidelity PCR products, such as cloning and high-throughput sequencing, but should not be used where 3'-A overhangs or sticky ends are required.

• DPP9 Mutation Drives Hyperinflammation via Inflammasome Dere

  2026-05-11

  Wolf et al. report a de novo DPP9 mutation that destabilizes the protein, resulting in unrestrained activation of the NLRP1 and CARD8 inflammasomes and severe infancy-onset autoinflammation. These findings clarify DPP9's essential regulatory role in inflammasome homeostasis and inform mechanistic studies of DPP family inhibitors in immune modulation.

• Pifithrin-α: Precision p53 Inhibitor for Ferroptosis & Apopt

  2026-05-10

  Pifithrin-α stands as the gold-standard p53 inhibitor for dissecting apoptosis, cell cycle arrest, and ferroptosis in both neurotoxicity and oncology models. Recent mechanistic breakthroughs—especially in neurodevelopmental protection—underscore its unique role in translating bench assays into actionable, disease-relevant insights.

• Peroxidasin Drives GBM Progression via LDHA-Mediated Glycoly

  2026-05-09

  This study identifies peroxidasin (PXDN) as a pivotal promoter of glycolytic metabolism and malignancy in glioblastoma, acting through regulation of lactate dehydrogenase A (LDHA). The findings provide mechanistic insight into tumor bioenergetics and suggest PXDN as a diagnostic and therapeutic target in GBM.

• APEX2 Regulates TERT Expression in Human Stem Cells and Mela

  2026-05-08

  This study identifies a novel role for the DNA repair enzyme APEX2 in promoting efficient TERT gene expression in human embryonic stem cells and melanoma, independent of its paralog APEX1. The findings reveal mechanistic insights into telomerase regulation via repetitive DNA elements, with implications for cancer and stem cell biology.

• BML-277 and the Chk2–cGAS Axis: New Frontiers in Genome Inte

  2026-05-08

  This article delivers a strategic, evidence-based exploration of BML-277—a highly selective Chk2 inhibitor—and its role in dissecting the emerging Chk2–cGAS regulatory axis in DNA damage response research. By synthesizing mechanistic advances, translational guidance, and protocol recommendations, it empowers researchers to design next-generation studies in radioprotection, cancer biology, and genome stability.

• Spiroplasma eriocheiris Invades Drosophila S2 Cells via Clat

  2026-05-07

  This study reveals that Spiroplasma eriocheiris infects Drosophila Schneider 2 cells predominantly via clathrin-mediated endocytosis and macropinocytosis, with dynamin inhibition significantly reducing bacterial entry. The findings clarify the molecular basis of host-pathogen interactions in invertebrate models and provide a robust experimental system for dissecting endocytic pathways.

• ApexPrep DNA Plasmid Miniprep Kit: Advanced Strategies for H

  2026-05-07

  Explore how the ApexPrep DNA Plasmid Miniprep Kit delivers molecular biology grade plasmid DNA for complex hematologic studies. Uncover advanced extraction strategies, protocol nuances, and practical insights that set this kit apart for cutting-edge leukemia research.

• Recombinant Mouse M-CSF: Protocols & Troubleshooting for Mac

  2026-05-06

  Unlock superior macrophage differentiation, osteoclast progenitor proliferation, and immune modulation workflows using APExBIO's high-purity Recombinant Mouse M-CSF. Explore stepwise experimental enhancements, advanced applications in fibrosis and oncology, and troubleshooting strategies rooted in the latest mechanistic insights.

• Thiothixene: Integrating Efferocytosis Modulation in Psychot

  2026-05-06

  Explore how Thiothixene, a typical antipsychotic agent, uniquely bridges neuropharmacology and immunological efferocytosis enhancement. This article unveils advanced assay design and mechanistic insights that go beyond standard protocols.

• Wnt Agonist 1: Driving Precision in Wnt Pathway Cellular Dif

  2026-05-05

  Wnt agonist 1 (BML-284) enables robust, reproducible activation of canonical Wnt signaling for developmental and cancer biology research. This guide details experimental workflows, troubleshooting strategies, and advanced assay applications, leveraging recent findings on Wnt-driven chemoresistance and translational model optimization.

8667 records 15/578 page Previous Next First page 上5页 1112131415 下5页 Last page